Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma

Published:2019-02-04 Issue:6 Volume:39 Page:1033-1043
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Piñero Federico¹^ORCID,Mendizabal Manuel¹,Ridruejo Ezequiel¹²,Herz Wolff Fernando³,Ameigeiras Beatriz⁴,Anders Margarita⁵,Schinoni María Isabel⁶,Reggiardo Virginia⁷,Palazzo Ana⁸,Videla María⁹,Alonso Cristina¹,Santos Luisa¹⁰,Varón Adriana¹⁰,Figueroa Sebastián¹¹,Vistarini Cecilia⁴,Adrover Raúl¹²,Fernández Nora¹³,Perez Daniela⁸,Tanno Federico⁷,Hernández Nelia¹⁴,Sixto Marcela¹⁵,Borzi Silvia¹⁶,Bruno Andres¹⁷,Cocozzella Daniel¹²,Soza Alejandro¹⁸,Descalzi Valeria¹⁹,Estepo Claudio¹⁷,Zerega Alina²⁰,de Araujo Alexandre²¹,Cheinquer Hugo³,Silva Marcelo¹,

Affiliation:

1. Hospital Universitario Austral Pilar Argentina

2. Centro de Educación Médica e Investigaciones Clínicas Buenos Aires Argentina

3. Universidade Federal do Rio Grande do Sul Porto Alegre RS Brazil

4. Hospital Ramos Mejía Buenos Aires Argentina

5. Hospital Alemán Buenos Aires Argentina

6. Universidade Federal do Bahia Salvador Brazil

7. Hospital Centenario de Rosario Rosario Argentina

8. Hospital Padilla San Miguel de Tucumán Argentina

9. Sanatorio Sagrado Corazón Buenos Aires Argentina

10. Fundación Cardioinfantil Bogota Colombia

11. Sanatorio Parque Salta Argentina

12. Hospital San Roque Buenos Aires Argentina

13. Hospital Británico Buenos Aires Argentina

14. Hospital Clínico Montevideo Uruguay

15. Hospital Jose María Cullen Santa Fe Argentina

16. Hospital Rossi Buenos Aires Argentina

17. Hospital Cosme Argerich Buenos Aires Argentina

18. Hospital Pontificia Universidad Católica de Chile Santiago Chile

19. Fundación Favaloro Buenos Aires Argentina

20. Sanatorio Allende Córdoba Argentina

21. Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Funder

AbbVie

Bristol-Myers Squibb

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14041

Reference32 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

3. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

4. Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

5. EASL Recommendations on Treatment of Hepatitis C 2018

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices;Pharmacological Reports;2024-08-20

2. Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices;2024-05-13

3. Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress;Journal of Drug Delivery Science and Technology;2024-03

4. Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays;Chemical Biology & Drug Design;2024-03

5. Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma;Biomarkers;2024-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3